Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-002825

SVP, Controller and PAO sold 4,000 shares at $140.65 ($562,600)

  • SVP, Controller and PAO acquired 4,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Huizenga Theodore Alan · SVP, Controller and PAO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-07 Exercise or conversion : show line 1 in the form +4,000 $21.00 $84,000 20,436 D
2021-01-07 Sale : show line 2 in the form −4,000 $140.65 $562,600 15,716 D
Open-market sales · 4,000 sh · avg $140.65 · $562,600

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-01-07 Exercise or conversion : show line 3 in the form Stock Option −4,000 $21.00 2024-01-29 4,000 8,000 D
Loading xslF345X03/doc4.xml…